Skip to main content

Peer Review reports

From: Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma

Original Submission
27 Oct 2021 Submitted Original manuscript
19 Feb 2022 Reviewed Reviewer Report
25 Feb 2022 Reviewed Reviewer Report
10 Mar 2022 Author responded Author comments - Hodaka Yamada
11 Mar 2022 Author responded Author comments - Hodaka Yamada
Resubmission - Version 2
10 Mar 2022 Submitted Manuscript version 2
25 Mar 2022 Reviewed Reviewer Report
26 Mar 2022 Reviewed Reviewer Report
4 Apr 2022 Author responded Author comments - Hodaka Yamada
Resubmission - Version 3
4 Apr 2022 Submitted Manuscript version 3
5 Apr 2022 Author responded Author comments - Hodaka Yamada
Resubmission - Version 4
5 Apr 2022 Submitted Manuscript version 4
12 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
13 Apr 2022 Editorially accepted
26 Apr 2022 Article published 10.1186/s12902-022-01024-4

You can find further information about peer review here.

Back to article page